2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 以往年度的回顾文章参见 Nat Rev Drug Discov|2022年销售额排名Top10的制药公司和药品 Nat Rev Drug Discov|2021年制药公司和药物的销售额Top10 正如人们所预料的那样,2023年...
2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 正如人们所预料的那样,2023年制药行业的排名榜发生了变化。辉瑞因其COVID-19疫苗Comirnaty的巨大销售额而连续多年稳居榜首,但后来却一落千丈,由强生取而代之(图1a)。这一新的市...
Global overview Top companies' top products Best-selling drugs U.S. overview Outlook The most important statistics Pharmaceutical market: worldwide revenue 2001-2023 Top 50 pharmaceutical companies - Rx sales and R&D spending 2023 Top global biopharma drugs by lifetime sales up to 2028 ...
This statistic shows the ranking of the global top 10 biotech and pharmaceutical companies worldwide, based on revenue.
The pharmaceutical industry continues to generate stellar growth and was estimated to be worth an impressive US$1.6 trillion in 2023 with top 10 pharma companies contributing US$491.84 billion, nearly a third of all revenues. In this blog, we reveal the
Sales of consumer goods rose 12.5 percent year on year in 2021, NBS data showed, putting the average annual growth for the past two years at 3.9 percent. In December, the total retail sales of consumer goods grew by 1.7 percent year on year, according to the data. ...
The top 20 pharma companies by 2022 revenue At the bottom of the rankings, dropping out of the top 20, were prolific COVID vaccine sellers Moderna and BioNTech, which occupied the No. 18 and No. 20 slots, respectively, in 2022, with sales of $19.3 billion and 17.3 billion euros ($18.2...
release the2021 State of Nonprofit Marketing Reportin partnership with the Salesforce.com research team. This report contains responses that have been analyzed from 390 nonprofit marketers around the world as part of a broader survey of 8,200 marketers, including corporations and nonprofit ...
The North America is expected to hold largest revenue share throughout the forecast period, owing to the increase in adoption of advanced immunology drugs and the increasing prevalence of autoimmune and immunological disorders. The Europe is anticipated to be the second...
The emotions of those times remain Amid the rush to develop and deliver effective vaccines and close—and the easy and quick fix may still be, can we just keep it drugs for COVID, demands on companies were many. They out of our consciousness for the time being? But, of course, along ...